These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19008776)

  • 1. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
    Kissinger P; Amedee A; Clark RA; Dumestre J; Theall KP; Myers L; Hagensee ME; Farley TA; Martin DH
    Sex Transm Dis; 2009 Jan; 36(1):11-6. PubMed ID: 19008776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-occurrence of Trichomonas vaginalis and bacterial vaginosis and vaginal shedding of HIV-1 RNA.
    Fastring DR; Amedee A; Gatski M; Clark RA; Mena LA; Levison J; Schmidt N; Rice J; Gustat J; Kissinger P
    Sex Transm Dis; 2014 Mar; 41(3):173-9. PubMed ID: 24521723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.
    Masese LN; Graham SM; Gitau R; Peshu N; Jaoko W; Ndinya-Achola JO; Mandaliya K; Richardson BA; Overbaugh J; McClelland RS
    BMC Infect Dis; 2011 Nov; 11():307. PubMed ID: 22047086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women.
    Adamski A; Clark RA; Mena L; Henderson H; Levison J; Schmidt N; Gebrekristos HT; Martin DH; Kissinger P
    Clin Infect Dis; 2014 Sep; 59(6):883-7. PubMed ID: 24917661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.
    Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P
    Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
    Balkus JE; Richardson BA; Mochache V; Chohan V; Chan JD; Masese L; Shafi J; Marrazzo J; Farquhar C; McClelland RS
    Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
    Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study.
    Sgibnev A; Kremleva E
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):345-351. PubMed ID: 31705339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.
    Wang CC; McClelland RS; Reilly M; Overbaugh J; Emery SR; Mandaliya K; Chohan B; Ndinya-Achola J; Bwayo J; Kreiss JK
    J Infect Dis; 2001 Apr; 183(7):1017-22. PubMed ID: 11237825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Attitudes for Belgian Women With Persistent Trichomonas vaginalis Infection in the VlaResT Study.
    Donders GGG; Ruban K; Depuydt C; Bellen G; Vanden Broeck D; Jonckheere J; Jacquemyn Y
    Clin Infect Dis; 2019 Apr; 68(9):1575-1580. PubMed ID: 30395193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
    Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
    Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trichomoniasis therapy on genital HIV viral burden among African women.
    Anderson BL; Firnhaber C; Liu T; Swarts A; Siminya M; Ingersoll J; Caliendo AM; Cu-Uvin S
    Sex Transm Dis; 2012 Aug; 39(8):638-42. PubMed ID: 22797689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a nonhuman primate model for Trichomonas vaginalis infection.
    Patton DL; Sweeney YT; Agnew KJ; Balkus JE; Rabe LK; Hillier SL
    Sex Transm Dis; 2006 Dec; 33(12):743-6. PubMed ID: 16691156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.
    Gatski M; Martin DH; Levison J; Mena L; Clark RA; Murphy M; Henderson H; Schmidt N; Kissinger P
    Sex Transm Infect; 2011 Apr; 87(3):205-8. PubMed ID: 21278401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged vaginal and oral metronidazole for refractory Trichomonas vaginalis: a case report.
    Wood S; Kennedy CM; Galask RP
    J Reprod Med; 2007 Nov; 52(11):1057-8. PubMed ID: 18161407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol consumption and HIV-1 vaginal RNA shedding among women.
    Theall KP; Amedee A; Clark RA; Dumestre J; Kissinger P
    J Stud Alcohol Drugs; 2008 May; 69(3):454-8. PubMed ID: 18432389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalcitrant Trichomonas vaginalis infections successfully treated with vaginal acidification.
    Aggarwal A; Shier RM
    J Obstet Gynaecol Can; 2008 Jan; 30(1):55-58. PubMed ID: 18198069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues.
    Kissinger P
    BMC Infect Dis; 2015 Aug; 15():307. PubMed ID: 26242185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.